Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Auris, Nasus, Larynx|March 24, 2018
Multicenter phase I/II study of chemoradiotherapy with high-dose CDDP for head and neck squamous cell carcinoma in JapanHiroshi Matsuyama, Keisuke Yamazaki, Ryuichi Okabe, et al.
International Journal of Clinical Oncology|February 9, 2026
Modified EXTREME regimen versus modified TPEx regimen as first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, open-label, randomized, exploratory study (TEMPER study)Motoyuki Suzuki, Akehito Kishino, Masashi Sugasawa, et al.
Oncotarget|November 29, 2016
Impact of hematological inflammatory markers on clinical outcome in patients with salivary duct carcinoma: a multi-institutional study in JapanDaisuke Kawakita, Yuichiro Tada, Yorihisa Imanishi, et al.
Head & Neck|July 31, 2026
Biomarker-Driven Initial Systemic Therapy Enabling Curative-Intent Treatment in Non-Metastatic Unresectable Salivary Duct Carcinoma: A Multi-Institutional Retrospective StudySatoshi Kano, Daisuke Kawakita, Yoshitaka Honma, et al.
Oncotarget|September 24, 2017
Biomarker immunoprofile in salivary duct carcinomas: clinicopathological and prognostic implications with evaluation of the revised classificationSoichiro Takase, Satoshi Kano, Yuichiro Tada, et al.
Frontiers in Immunology|January 27, 2025
Nationwide multi-centric prospective study for the identification of biomarkers to predict the treatment responses of nivolumab through comprehensive analyses of pretreatment plasma exosome mRNAs from head and neck cancer patients (BIONEXT study)Kuniaki Sato, Satoshi Toh, Taku Murakami, et al.
Histopathology|July 12, 2018
The high expression of FOXA1 is correlated with a favourable prognosis in salivary duct carcinomas: a study of 142 casesMakoto Urano, Hideaki Hirai, Yuichiro Tada, et al.
The American Journal of Surgical Pathology|November 26, 2019
Prognostic Implication of Histopathologic Indicators in Salivary Duct Carcinoma: Proposal of a Novel Histologic Risk Stratification ModelMasato Nakaguro, Yukiko Sato, Yuichiro Tada, et al.
Virchows Archiv : an International Journal of Pathology|July 23, 2024
The clinicopathological and prognostic significance of autonomic nerves in salivary duct carcinomaManami Kajiwara, Hideaki Takahashi, Masato Nakaguro, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 9, 2025
Cytoplasmic p53 Immunostaining in Salivary Duct Carcinoma: A Poor Prognostic Factor Associated With Characteristic TP53 VariantsYoshitaka Utsumi, Masato Nakaguro, Daisuke Kawakita, et al.
Pageof 6